"Abortifacient Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances that interrupt pregnancy after implantation.
Descriptor ID |
D000019
|
MeSH Number(s) |
D27.505.696.875.131 D27.505.954.705.131
|
Concept/Terms |
Abortifacient Agents- Abortifacient Agents
- Agents, Abortifacient
- Contraceptive Agents, Postconception
- Agents, Postconception Contraceptive
- Postconception Contraceptive Agents
- Abortifacients
Abortifacient Effect- Abortifacient Effect
- Effect, Abortifacient
- Abortifacient Effects
- Effects, Abortifacient
|
Below are MeSH descriptors whose meaning is more general than "Abortifacient Agents".
Below are MeSH descriptors whose meaning is more specific than "Abortifacient Agents".
This graph shows the total number of publications written about "Abortifacient Agents" by people in this website by year, and whether "Abortifacient Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Abortifacient Agents" by people in Profiles.
-
Pearlman Shapiro M, Dethier D, Kahili-Heede M, Kaneshiro B. No-Test Medication Abortion: A Systematic Review. Obstet Gynecol. 2023 01 01; 141(1):23-34.
-
Kerestes C, Delafield R, Elia J, Chong E, Kaneshiro B, Soon R. "It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care. Contraception. 2021 07; 104(1):67-72.
-
Kerestes C, Murayama S, Tyson J, Natavio M, Seamon E, Raidoo S, Lacar L, Bowen E, Soon R, Platais I, Kaneshiro B, Stowers P. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models. Contraception. 2021 07; 104(1):49-53.
-
Raymond E, Chong E, Winikoff B, Platais I, Mary M, Lotarevich T, Castillo PW, Kaneshiro B, Tschann M, Fontanilla T, Baldwin M, Schnyer A, Coplon L, Mathieu N, Bednarek P, Keady M, Priegue E. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States. Contraception. 2019 09; 100(3):173-177.